MedX Health Corp announced that seasoned pharmaceutical finance executive Lesley Bourget will be joining the company as its chief financial officer on November 8, 2021.
The Mississauga, Ontario-based company shared that Bourget’s appointment will further support MedX’s global commercialization strategy, as the company seeks to build on the momentum of current commercial and product distribution pilots underway across North America and Europe, with additional pilots anticipated in the coming months.
READ: MedX Health and partner to run pilot program for its DermSecure Screening Platform in Italy
“On behalf of MedX’s board of directors and leadership team, I want to warmly welcome Lesley as she takes on the pivotal CFO role during a time of rapid growth for our Company,” said Sylvain Desjeans, MedX CEO, in a release.
Desjeans added, “Lesley is an inspirational and visionary leader, with a long track record of supporting market growth through her extensive M&A negotiation and alliance-building experience for public pharmaceutical and healthcare companies.”
Bourget comes with more than 30 years of experience in healthcare, pharmaceutical, and CPG industries, and has a proven track record for generating profits by successfully leading product profile portfolio optimization efforts, negotiating large-scale acquisitions, and conceiving and implementing mergers in the R&D space.
The new member of MedX’s team most recently served as CFO of Aspen Pharmacare (JSE:APN) Canada, where she was instrumental in achieving company-record profit levels, and optimizing inventory and wholesaler processes.
“I was drawn to MedX due to its mission of saving lives and its technology’s unique ability to make teledermatology accessible for patients around the world,” Bourget said. “Strengthening virtual healthcare services has never been more important than it is now, amid a global pandemic. I feel privileged to join the MedX team to help fulfill its growth potential and improve patient outcomes.”
Teledermatology is a subspecialty of dermatology that offers safe and effective virtual care – both patient screening and assessment – eliminating the need for in-person appointments with a dermatologist.
MedX, a leading medical device and software company, is focused on skin health through its patented technology and products that have been approved by Health Canada, the US Food and Drug Administration, the Therapeutic Goods Administration, and Conformité Européenne for use in Canada, the US, Australia, New Zealand, the European Union, Brazil, and Turkey.
Contact Ritika at ritika@proactiveinvestors.com